"Not to mention that we could get Breakthrough Device Designation any day now."
That could well be the case Eire. A link below to an article - FDA Anticipates Fewer Novel Medical Device Approvals in 2022 -
https://www.fiercebiotech.com/medtech/fda-anticipates-fewer-novel-medical-device-approvals-2022?utm_source=email&utm_medium=email&utm_campaign=LS-NL-FiercePharma+Tracker&oly_enc_id=9563F4064234D3D
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-17
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
0.000(0.00%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 84 | $17.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.55 | 2204 | 3 |
View Market Depth
| Last trade - 15.34pm 23/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable